首页> 外文期刊>Psychosomatic Medicine: Journal of the American Psychosomatic Society >Assessing the New DSM-5 Diagnosis of Somatic Symptom Disorder
【24h】

Assessing the New DSM-5 Diagnosis of Somatic Symptom Disorder

机译:评估躯体症状障碍的新DSM-5诊断

获取原文
获取原文并翻译 | 示例
           

摘要

The conceptualization of somatization and what were previously termed somatoform disorders has changed substantially in the DSM-5 compared with previous diagnostic systems. The current diagnostic criteria for somatic symptom disorder (SSD) require the presence of symptoms (Criterion A) combined with a substantial impact of these symptoms on thoughts, emotions, and behaviors (Criterion B). In this issue of Psychosomatic Medicine, Toussaint et al. describe the development and empirical validation of a self-report questionnaire the SSD-12 to assess the new psychological criteria (the B criteria) of DSM-5 SSD. This is an important contribution because previously there was no questionnaire available to assess the B Criterion of SSD. The new DSM-5 criteria for SSD no longer require the absence of an adequate medical explanation for a somatic symptom, but rather define positive diagnostic criteria, focusing on the psychological impact of the somatic symptoms rather than their purported (medical) cause. Although this new conceptualization of somatization-related disorders has several advantages, seriously ill medical patients may well score high on the B Criterion for SSD on that basis alone and not because their psychological response to the medical illness is disproportionate or excessive. Measures of medical morbidity therefore need to be included in the interpretation of the SSD in individuals with severe medical conditions. Given the revised DSM-5 criteria, the newly developed and validated SSD-12 is a useful tool for diagnosing and monitoring treatment response in SSD.
机译:与以前的诊断系统相比,DSM-5中的躯体化概念和以前称为躯体形式障碍的概念已发生了重大变化。当前针对躯体症状障碍(SSD)的诊断标准要求存在症状(标准A),并结合这些症状对思想,情感和行为的重大影响(标准B)。在本期《心身医学》中,Toussaint等人。描述自我报告调查问卷SSD-12的发展和经验验证,以评估DSM-5 SSD的新心理标准(B标准)。这是一项重要的贡献,因为以前没有可用的问卷来评估SSD的B标准。针对SSD的新DSM-5标准不再需要缺少针对躯体症状的医学解释,而是定义阳性诊断标准,重点放在躯体症状的心理影响上,而不是其所谓的(医学)原因。尽管这种新的与躯体化有关的疾病的概念化具有多个优点,但仅凭此基础,重症医学患者就可以在SSD的B标准中获得很高的评分,而不是因为他们对医学疾病的心理反应不相称或过高。因此,对于患有严重疾病的人,在对SSD的解释中需要包括对疾病发病率的测量。考虑到修订后的DSM-5标准,新开发和验证的SSD-12是诊断和监视SSD中治疗反应的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号